HONG KONG – November 03, 2026 -- WuXi Biologics (2269.HK) won two Grand Awards at the ninth Hong Kong ESG Reporting Awards (HERA), the only pharmaceutical company to do so among 120 entries.
MINNEAPOLIS – – November 03, 2026 -- Bio-Techne Corporation (NASDAQ: TECH) will pay a quarterly dividend of $0.08 per share only if its pending transaction with Merck KGaA, Darmstadt, Germany has not closed by the close of business on November 13, 2026.
TOKYO – November 03, 2026 -- Japan's market for EMR-derived healthcare data is projected to grow from about ¥3.9 billion in 2025 to about ¥25 billion in 2035, according to a whitepaper from TXP Medical Co., Ltd. The report, "The State of Japanese Real-World Evidence," targets pharmaceutical Medical Affairs departments. It is the first publication from the company's relaunched "Medical Data Lab" media unit.
WASHINGTON – November 03, 2026 -- The President has signed the ACT for ALS reauthorization bill into law, extending the program for five years and committing up to an additional $500 million to ALS research infrastructure and investigational treatment access, according to patient advocacy group I AM ALS.
Arlington, Virginia – November 03, 2026 -- The President has signed the bipartisan ACT for ALS Act into law, extending the research and treatment access programs created under the original 2021 legislation through 2031, according to the ALS Association.
SUNNYVALE – – November 03, 2026 -- Cepheid, a Danaher operating company, has received U.S. Food and Drug Administration clearance for the Xpert Hemorrhagic Fever Panel, a multiplex PCR test that detects four hemorrhagic fever virus groups from a single sample in approximately 61 minutes.
Bronx, N.Y. – – November 03, 2026 -- The National Cancer Institute (NCI) has awarded a five-year, $10 million grant to a multi-institutional team led by Julio A. Aguirre-Ghiso, Ph.D., of Montefiore Einstein Comprehensive Cancer Center (MECCC). The money will fund research into the biological processes behind breast cancer relapse and into ways to predict and prevent recurrence.
Philadelphia – November 03, 2026 -- Signant Health has launched SignalSpace, a connected environment that combines its applications, study activity, support, workflows, data and AI-guided intelligence in one secure destination for sites, sponsors and CROs. SignalSpace comes standard with Signant solutions.
Cambridge, Mass. – November 03, 2026 -- Zifo has launched an AI-assisted service accelerator that it estimates could cut computer system validation (CSV) documentation effort by up to 60 to 70 percent for regulated scientific organizations.
Irvine, California – November 03, 2026 -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), will present nine abstracts at the 2026 American Society for Dermatologic Surgery (ASDS) Annual Meeting, Nov. 5-8 in San Diego, including new data from two Phase 4 studies on aesthetic treatment in patients taking GLP-1-related medications for weight management.
